ckcy的个人主页 - 老虎社区

ckcy

ckcy

暂无个人介绍

IP属地：未知

66关注

4粉丝

0主题

0勋章

2021-11-06

Still TSM is solid

Semiconductor stocks climbed in morning trading

2021-11-20

Holding. DCA

Boeing Dreamliner Defects Bog Down Production

2021-12-03

Thanks

Toplines Before US Market Open on Friday

2021-11-06

Waiting to buy

Why Palantir Stock Offers a Bit of Something for Everyone

2021-11-06

Watching arkk

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

2021-11-11

Keeping.

Analysts Adjust Palantir Price Targets Post Q3 Results

2021-11-06

I am interested in this

It's Time to Buy Novavax After the Biotech's Q3 Update

2021-11-12

Holding

TSMC shares fell 1.42% in premarket trading

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4097660307195980,"uuid":"4097660307195980","gmtCreate":1634917148505,"gmtModify":1635783623373,"name":"ckcy","pinyin":"ckcy","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":4,"headSize":66,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.80%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.45%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":601258235,"gmtCreate":1638538429344,"gmtModify":1638538429344,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601258235","repostId":"1164605320","repostType":2,"repost":{"id":"1164605320","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638538539,"share":"https://www.laohu8.com/m/news/1164605320?lang=&edition=full","pubTime":"2021-12-03 21:35","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1164605320","media":"Tiger Newspress","summary":"U.S. stock index futures gains as headline number for jobs report comes in lighter than expected.At 8:34 a.m. ET, Dow e-minis were up 121 points, or 0.35%, S&P 500 e-minis were up 20.5 points, or 0.45%, and Nasdaq 100 e-minis were up 103.25 points, or 0.65%.The U.S. economy created far fewer jobs than expected in November, before a new Covid threat created a scare that growth could slow into the winter, the Labor Department reported Friday.Nonfarm payrolls increased by just 210,000 for the month","content":"<p>U.S. stock index futures gains as headline number for jobs report comes in lighter than expected.</p>\n<p>At 8:34 a.m. ET, Dow e-minis were up 121 points, or 0.35%, S&amp;P 500 e-minis were up 20.5 points, or 0.45%, and Nasdaq 100 e-minis were up 103.25 points, or 0.65%.</p>\n<p><img src=\"https://static.tigerbbs.com/20c2b6513372a62312316352a7b69eeb\" tg-width=\"404\" tg-height=\"183\" referrerpolicy=\"no-referrer\"></p>\n<p>The U.S. economy created far fewer jobs than expected in November, before a new Covid threat created a scare that growth could slow into the winter, the Labor Department reported Friday.</p>\n<p>Nonfarm payrolls increased by just 210,000 for the month, though the unemployment rate fell sharply to 4.2% from 4.6%, even though the labor force participation rate increased for the month to 61.8%, its highest level since March 2020.</p>\n<p>The Dow Jones estimate was for 573,000 new jobs and a jobless level of 4.5%.</p>\n<p><b>Stocks making the biggest moves before the bell:</b></p>\n<p><b>DocuSign(DOCU) </b>- The software stock sank 32% after its&nbsp;fourth-quarter sales guidance came in at a range of $557 million to $563 million. Analysts surveyed by Refinitiv were expecting $573.8 million.</p>\n<p><b>Didi Global(DIDI) </b>- Shares of the Chinese ride-hailing firm&nbsp;dropped 10% in premarket trading&nbsp;after Didi announced that it would delist from the New York Stock Exchange and pursue a listing in Hong Kong.</p>\n<p><b>Peloton(PTON)</b> - The exercise equipment stock gained 3.7% before the bell following an&nbsp;initiation at buy from Deutsche Bank. The investment firm said that Peloton’s upside now outweighed its risks after a rough stretch for the stock.</p>\n<p><b>Moderna(MRNA) </b>- The volatile shares of the vaccine maker jumped 5.8% as the&nbsp;Wall Street Journal&nbsp;reported that the Food and Drug Administration is working toward a quick review process for updated Covid shots.</p>\n<p><b>Ulta Beauty(ULTA)</b> - The cosmetics retailer’s stock rose more than 5% after a stronger-than-expected third-quarter report. Ulta earned $3.93 per share on $2 billion in revenue during the quarter. Analysts surveyed by Refinitiv had expected $2.46 per share and $1.88 billion in revenue.</p>\n<p><b>Marvell Technology(MRVL)</b> - Shares of the chipmaker jumped 22% in premarket trading after Marvell beat estimates on the top and bottom lines for the third quarter. Marvell reported adjusted earnings of 43 cents per share on $1.21 billion of revenue. Analysts surveyed by Refinitiv were looking for 39 cents per share and $1.15 billion.</p>\n<p><b>Ollie's Bargain Outlet(OLLI) </b>- The discount retail chain's stock dropped 22.8% after Ollie's said supply chain issues led to a disappointing third-quarter report. The company missed estimates for earnings, revenue and comparable sales.</p>\n<p><b>Big Lots(BIG)</b> - The retail stock dipped 2.5% despite Big Lots reporting a narrower-than-expected loss per share for the third quarter. The company said that freight costs would make its full-year margins decline.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-03 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures gains as headline number for jobs report comes in lighter than expected.</p>\n<p>At 8:34 a.m. ET, Dow e-minis were up 121 points, or 0.35%, S&amp;P 500 e-minis were up 20.5 points, or 0.45%, and Nasdaq 100 e-minis were up 103.25 points, or 0.65%.</p>\n<p><img src=\"https://static.tigerbbs.com/20c2b6513372a62312316352a7b69eeb\" tg-width=\"404\" tg-height=\"183\" referrerpolicy=\"no-referrer\"></p>\n<p>The U.S. economy created far fewer jobs than expected in November, before a new Covid threat created a scare that growth could slow into the winter, the Labor Department reported Friday.</p>\n<p>Nonfarm payrolls increased by just 210,000 for the month, though the unemployment rate fell sharply to 4.2% from 4.6%, even though the labor force participation rate increased for the month to 61.8%, its highest level since March 2020.</p>\n<p>The Dow Jones estimate was for 573,000 new jobs and a jobless level of 4.5%.</p>\n<p><b>Stocks making the biggest moves before the bell:</b></p>\n<p><b>DocuSign(DOCU) </b>- The software stock sank 32% after its&nbsp;fourth-quarter sales guidance came in at a range of $557 million to $563 million. Analysts surveyed by Refinitiv were expecting $573.8 million.</p>\n<p><b>Didi Global(DIDI) </b>- Shares of the Chinese ride-hailing firm&nbsp;dropped 10% in premarket trading&nbsp;after Didi announced that it would delist from the New York Stock Exchange and pursue a listing in Hong Kong.</p>\n<p><b>Peloton(PTON)</b> - The exercise equipment stock gained 3.7% before the bell following an&nbsp;initiation at buy from Deutsche Bank. The investment firm said that Peloton’s upside now outweighed its risks after a rough stretch for the stock.</p>\n<p><b>Moderna(MRNA) </b>- The volatile shares of the vaccine maker jumped 5.8% as the&nbsp;Wall Street Journal&nbsp;reported that the Food and Drug Administration is working toward a quick review process for updated Covid shots.</p>\n<p><b>Ulta Beauty(ULTA)</b> - The cosmetics retailer’s stock rose more than 5% after a stronger-than-expected third-quarter report. Ulta earned $3.93 per share on $2 billion in revenue during the quarter. Analysts surveyed by Refinitiv had expected $2.46 per share and $1.88 billion in revenue.</p>\n<p><b>Marvell Technology(MRVL)</b> - Shares of the chipmaker jumped 22% in premarket trading after Marvell beat estimates on the top and bottom lines for the third quarter. Marvell reported adjusted earnings of 43 cents per share on $1.21 billion of revenue. Analysts surveyed by Refinitiv were looking for 39 cents per share and $1.15 billion.</p>\n<p><b>Ollie's Bargain Outlet(OLLI) </b>- The discount retail chain's stock dropped 22.8% after Ollie's said supply chain issues led to a disappointing third-quarter report. The company missed estimates for earnings, revenue and comparable sales.</p>\n<p><b>Big Lots(BIG)</b> - The retail stock dipped 2.5% despite Big Lots reporting a narrower-than-expected loss per share for the third quarter. The company said that freight costs would make its full-year margins decline.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTON":"Peloton Interactive, Inc.",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","BIG":"必乐透","MRVL":"迈威尔科技","OLLI":"Ollie's Bargain Outlet Holdings, Inc.","DIDI":"滴滴(已退市)",".SPX":"S&P 500 Index","DOCU":"Docusign","MRNA":"Moderna, Inc.","ULTA":"Ulta美容"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164605320","content_text":"U.S. stock index futures gains as headline number for jobs report comes in lighter than expected.\nAt 8:34 a.m. ET, Dow e-minis were up 121 points, or 0.35%, S&P 500 e-minis were up 20.5 points, or 0.45%, and Nasdaq 100 e-minis were up 103.25 points, or 0.65%.\n\nThe U.S. economy created far fewer jobs than expected in November, before a new Covid threat created a scare that growth could slow into the winter, the Labor Department reported Friday.\nNonfarm payrolls increased by just 210,000 for the month, though the unemployment rate fell sharply to 4.2% from 4.6%, even though the labor force participation rate increased for the month to 61.8%, its highest level since March 2020.\nThe Dow Jones estimate was for 573,000 new jobs and a jobless level of 4.5%.\nStocks making the biggest moves before the bell:\nDocuSign(DOCU) - The software stock sank 32% after its fourth-quarter sales guidance came in at a range of $557 million to $563 million. Analysts surveyed by Refinitiv were expecting $573.8 million.\nDidi Global(DIDI) - Shares of the Chinese ride-hailing firm dropped 10% in premarket trading after Didi announced that it would delist from the New York Stock Exchange and pursue a listing in Hong Kong.\nPeloton(PTON) - The exercise equipment stock gained 3.7% before the bell following an initiation at buy from Deutsche Bank. The investment firm said that Peloton’s upside now outweighed its risks after a rough stretch for the stock.\nModerna(MRNA) - The volatile shares of the vaccine maker jumped 5.8% as the Wall Street Journal reported that the Food and Drug Administration is working toward a quick review process for updated Covid shots.\nUlta Beauty(ULTA) - The cosmetics retailer’s stock rose more than 5% after a stronger-than-expected third-quarter report. Ulta earned $3.93 per share on $2 billion in revenue during the quarter. Analysts surveyed by Refinitiv had expected $2.46 per share and $1.88 billion in revenue.\nMarvell Technology(MRVL) - Shares of the chipmaker jumped 22% in premarket trading after Marvell beat estimates on the top and bottom lines for the third quarter. Marvell reported adjusted earnings of 43 cents per share on $1.21 billion of revenue. Analysts surveyed by Refinitiv were looking for 39 cents per share and $1.15 billion.\nOllie's Bargain Outlet(OLLI) - The discount retail chain's stock dropped 22.8% after Ollie's said supply chain issues led to a disappointing third-quarter report. The company missed estimates for earnings, revenue and comparable sales.\nBig Lots(BIG) - The retail stock dipped 2.5% despite Big Lots reporting a narrower-than-expected loss per share for the third quarter. The company said that freight costs would make its full-year margins decline.","news_type":1},"isVote":1,"tweetType":1,"viewCount":939,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876456630,"gmtCreate":1637346285190,"gmtModify":1637346285353,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Holding. DCA","listText":"Holding. DCA","text":"Holding. DCA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876456630","repostId":"1114542201","repostType":2,"repost":{"id":"1114542201","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637335740,"share":"https://www.laohu8.com/m/news/1114542201?lang=&edition=full","pubTime":"2021-11-19 23:29","market":"us","language":"en","title":"Boeing Dreamliner Defects Bog Down Production","url":"https://stock-news.laohu8.com/highlight/detail?id=1114542201","media":"Tiger Newspress","summary":"Boeing stock dropped 4% in morning trading as Boeing Dreamliner defected bog down production.\n\nBoein","content":"<p>Boeing stock dropped 4% in morning trading&nbsp;as&nbsp;Boeing Dreamliner defected bog down production.</p>\n<p><img src=\"https://static.tigerbbs.com/3c6c1e62a6a6a253da601f54af830508\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Boeing&nbsp;Co.&nbsp;has further slowed production of 787 Dreamliners as&nbsp;it addresses defects&nbsp;that&nbsp;are delaying deliveries of new jets&nbsp;and complicating airlines’ plans, people familiar with the matter said.</p>\n<p>The plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.</p>\n<p>The latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.</p>\n<p>A string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.</p>\n<p>A Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.</p>\n<p>Boeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.</p>\n<p>The company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.</p>\n<p>“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.</p>\n<p>In an Oct. 27 call with analysts, Chief Executive David Calhoun said&nbsp;defective titanium parts&nbsp;were the “long pole in the tent” among remaining production problems to address.</p>\n<p>The door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing&nbsp;has largely been dealing with tiny gaps&nbsp;where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.</p>\n<p>The Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.</p>\n<p>None of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.</p>\n<p>With deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.</p>\n<p>The delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.</p>\n<p>American Airlines Group&nbsp;Inc.&nbsp;said it had trimmed its flying plans due to the delayed arrival of its new 787s.</p>\n<p>“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.</p>\n<p>The FAA launched a broad review of Boeing’s Dreamliner production in late 2020.</p>\n<p>On Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.</p>\n<p>Representatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boeing Dreamliner Defects Bog Down Production</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoeing Dreamliner Defects Bog Down Production\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-19 23:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Boeing stock dropped 4% in morning trading&nbsp;as&nbsp;Boeing Dreamliner defected bog down production.</p>\n<p><img src=\"https://static.tigerbbs.com/3c6c1e62a6a6a253da601f54af830508\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Boeing&nbsp;Co.&nbsp;has further slowed production of 787 Dreamliners as&nbsp;it addresses defects&nbsp;that&nbsp;are delaying deliveries of new jets&nbsp;and complicating airlines’ plans, people familiar with the matter said.</p>\n<p>The plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.</p>\n<p>The latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.</p>\n<p>A string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.</p>\n<p>A Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.</p>\n<p>Boeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.</p>\n<p>The company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.</p>\n<p>“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.</p>\n<p>In an Oct. 27 call with analysts, Chief Executive David Calhoun said&nbsp;defective titanium parts&nbsp;were the “long pole in the tent” among remaining production problems to address.</p>\n<p>The door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing&nbsp;has largely been dealing with tiny gaps&nbsp;where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.</p>\n<p>The Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.</p>\n<p>None of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.</p>\n<p>With deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.</p>\n<p>The delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.</p>\n<p>American Airlines Group&nbsp;Inc.&nbsp;said it had trimmed its flying plans due to the delayed arrival of its new 787s.</p>\n<p>“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.</p>\n<p>The FAA launched a broad review of Boeing’s Dreamliner production in late 2020.</p>\n<p>On Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.</p>\n<p>Representatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BA":"波音"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114542201","content_text":"Boeing stock dropped 4% in morning trading as Boeing Dreamliner defected bog down production.\n\nBoeing Co. has further slowed production of 787 Dreamliners as it addresses defects that are delaying deliveries of new jets and complicating airlines’ plans, people familiar with the matter said.\nThe plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.\nThe latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.\nA string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.\nA Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.\nBoeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.\nThe company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.\n“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.\nIn an Oct. 27 call with analysts, Chief Executive David Calhoun said defective titanium parts were the “long pole in the tent” among remaining production problems to address.\nThe door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing has largely been dealing with tiny gaps where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.\nThe Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.\nNone of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.\nWith deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.\nThe delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.\nAmerican Airlines Group Inc. said it had trimmed its flying plans due to the delayed arrival of its new 787s.\n“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.\nThe FAA launched a broad review of Boeing’s Dreamliner production in late 2020.\nOn Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.\nRepresentatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":620,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879271161,"gmtCreate":1636731141461,"gmtModify":1636731141461,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Holding","listText":"Holding","text":"Holding","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879271161","repostId":"1154623739","repostType":2,"repost":{"id":"1154623739","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636544529,"share":"https://www.laohu8.com/m/news/1154623739?lang=&edition=full","pubTime":"2021-11-10 19:42","market":"us","language":"en","title":"TSMC shares fell 1.42% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1154623739","media":"Tiger Newspress","summary":"TSMC shares fell 1.42% in premarket trading.\n\nTaiwan Semiconductor Manufacturing Co.'s October reven","content":"<p>TSMC&nbsp;shares&nbsp;fell&nbsp;1.42%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/925cf65fc3c3ace443ec6883f6b03c59\" tg-width=\"878\" tg-height=\"612\" width=\"100%\" height=\"auto\"></p>\n<p>Taiwan Semiconductor Manufacturing Co.'s&nbsp;October revenue&nbsp;was up 12.8% Y/Y to NT$134.54B or about $4.86B.</p>\n<p>The sales were down 11.9% compared to September 2021.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TSMC shares fell 1.42% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTSMC shares fell 1.42% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-10 19:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TSMC&nbsp;shares&nbsp;fell&nbsp;1.42%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/925cf65fc3c3ace443ec6883f6b03c59\" tg-width=\"878\" tg-height=\"612\" width=\"100%\" height=\"auto\"></p>\n<p>Taiwan Semiconductor Manufacturing Co.'s&nbsp;October revenue&nbsp;was up 12.8% Y/Y to NT$134.54B or about $4.86B.</p>\n<p>The sales were down 11.9% compared to September 2021.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSM":"台积电"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154623739","content_text":"TSMC shares fell 1.42% in premarket trading.\n\nTaiwan Semiconductor Manufacturing Co.'s October revenue was up 12.8% Y/Y to NT$134.54B or about $4.86B.\nThe sales were down 11.9% compared to September 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":739,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870790830,"gmtCreate":1636645276027,"gmtModify":1636645735060,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Keeping.&nbsp;","listText":"Keeping.&nbsp;","text":"Keeping.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870790830","repostId":"1139881214","repostType":2,"repost":{"id":"1139881214","pubTimestamp":1636619165,"share":"https://www.laohu8.com/m/news/1139881214?lang=&edition=full","pubTime":"2021-11-11 16:26","market":"us","language":"en","title":"Analysts Adjust Palantir Price Targets Post Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1139881214","media":"Benzinga","summary":"Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.\nRBC Ca","content":"<p></p>\n<ul>\n <li><p>Few analysts slashed price targets on<b>Palantir Technologies Inc</b>(NYSE:PLTR)despite the Q3 beat.</p></li>\n <li><p><b>RBC Capital</b>analyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, down from $25, implying a 17% downside.</p></li>\n <li><p>The analyst cites the company's \"mixed\" Q3 results with deceleration in the government business while noting that its commercial acceleration that is being fueled by SPAC investments is \"unsustainable.\"</p></li>\n <li><p>Jaluria adds that his confidence in Palantr's 30% growth is reduced, and he sees the stock's valuation as \"full.\"</p></li>\n <li><p><b>William Blair</b>&nbsp;analyst Kamil Mielczarek says Palantir revenues decelerated in the quarter to 36% year-over-year, down from 49% in the first half of 2021.</p></li>\n <li><p>While Palantir delivered \"strong\" headline numbers, the growth in the second half of 2021 is \"heavily reliant on strategic investments.\"</p></li>\n <li><p>The analyst remains concerned about the business's ability to maintain 30% organic growth over the near term and keeps an Underperform rating on Palantir.</p></li>\n <li><p><b>Citi</b>&nbsp;analyst Tyler Radke states Palantir's decelerating growth \"came into center view\" in Q3 with weakness in both commercial and government.</p></li>\n <li><p>While guidance for Q4 was issued slightly ahead of the Street, it still implies slower growth, even on an easier comparison and with significant tailwinds from SPAC-related customer contracting.</p></li>\n <li><p>He reiterates a Sell rating on the shares with an $18 price target.</p></li>\n <li><p><b>Wolfe Research</b>&nbsp;analyst Alex Zukin lowered the price target to $20 from $25, and maintained a Peer Perform following what he calls an \"interesting\" Q3 report.</p></li>\n <li><p>He notes that shares were down after the announcement, which he blames a \"meaningful top-line deceleration,\" pointing out that total revenues, ex. SPAC-contributions of $373 million grew 29% year-over-year, which Zukin said is up only less than $1 million sequentially from Q2.</p></li>\n <li><p>His lower price target is due to the core growth deceleration as he is \"not yet comfortable assigning a similar confidence interval and multiple to SPAC-based commercial revenue.\"</p></li>\n <li><p><b>Morgan Stanley</b>&nbsp;analyst Keith Weiss raised the price target to $24 from $22, implying a 4% upside.</p></li>\n <li><p>He reiterated an Underweight after delivering another beat versus consensus expectations \"across all key headline metrics\" in Q3.</p></li>\n <li><p>Weiss sees \"signs of slowing underneath the hood\" as a slowdown in core revenue and commercial growth, coupled with a sharper slowdown in the government segment, which opens up the debate on the durability of Palantir's growth.</p></li>\n <li><p><b>Price Action:</b>PLTR shares traded lower by 5.6% at $22.9 on the last check Wednesday.</p></li>\n</ul>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Analysts Adjust Palantir Price Targets Post Q3 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnalysts Adjust Palantir Price Targets Post Q3 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-11 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.\nRBC Capitalanalyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139881214","content_text":"Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.\nRBC Capitalanalyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, down from $25, implying a 17% downside.\nThe analyst cites the company's \"mixed\" Q3 results with deceleration in the government business while noting that its commercial acceleration that is being fueled by SPAC investments is \"unsustainable.\"\nJaluria adds that his confidence in Palantr's 30% growth is reduced, and he sees the stock's valuation as \"full.\"\nWilliam Blair analyst Kamil Mielczarek says Palantir revenues decelerated in the quarter to 36% year-over-year, down from 49% in the first half of 2021.\nWhile Palantir delivered \"strong\" headline numbers, the growth in the second half of 2021 is \"heavily reliant on strategic investments.\"\nThe analyst remains concerned about the business's ability to maintain 30% organic growth over the near term and keeps an Underperform rating on Palantir.\nCiti analyst Tyler Radke states Palantir's decelerating growth \"came into center view\" in Q3 with weakness in both commercial and government.\nWhile guidance for Q4 was issued slightly ahead of the Street, it still implies slower growth, even on an easier comparison and with significant tailwinds from SPAC-related customer contracting.\nHe reiterates a Sell rating on the shares with an $18 price target.\nWolfe Research analyst Alex Zukin lowered the price target to $20 from $25, and maintained a Peer Perform following what he calls an \"interesting\" Q3 report.\nHe notes that shares were down after the announcement, which he blames a \"meaningful top-line deceleration,\" pointing out that total revenues, ex. SPAC-contributions of $373 million grew 29% year-over-year, which Zukin said is up only less than $1 million sequentially from Q2.\nHis lower price target is due to the core growth deceleration as he is \"not yet comfortable assigning a similar confidence interval and multiple to SPAC-based commercial revenue.\"\nMorgan Stanley analyst Keith Weiss raised the price target to $24 from $22, implying a 4% upside.\nHe reiterated an Underweight after delivering another beat versus consensus expectations \"across all key headline metrics\" in Q3.\nWeiss sees \"signs of slowing underneath the hood\" as a slowdown in core revenue and commercial growth, coupled with a sharper slowdown in the government segment, which opens up the debate on the durability of Palantir's growth.\nPrice Action:PLTR shares traded lower by 5.6% at $22.9 on the last check Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842697122,"gmtCreate":1636167670895,"gmtModify":1636167732252,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"I am interested in this","listText":"I am interested in this","text":"I am interested in this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842697122","repostId":"2181717655","repostType":4,"repost":{"id":"2181717655","pubTimestamp":1636109010,"share":"https://www.laohu8.com/m/news/2181717655?lang=&edition=full","pubTime":"2021-11-05 18:43","market":"us","language":"en","title":"It's Time to Buy Novavax After the Biotech's Q3 Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2181717655","media":"Motley Fool","summary":"Here are three reasons why.","content":"<p><b>Novavax</b> (NASDAQ:NVAX) has given plenty of reasons for skeptics to doubt whether or not it would be successful. You can go back to the company's multiple flops in clinical trials of its experimental respiratory syncytial virus vaccine over the past few years. You can also point to Novavax's repeated delays in filing for regulatory approvals and authorizations of its COVID-19 vaccine candidate NVX-Cov2373.</p>\n<p>However, Novavax announced its third-quarter results after the market closed on Thursday. I think that it's time to buy this vaccine stock after the biotech's Q3 update. Here are three reasons why.</p>\n<h2>1. Regulatory filings are on track</h2>\n<p>Novavax's management team at long last were able to point to successes with regulatory filings. NVX-CoV2373 even recently won its first Emergency Use Authorization (EUA) in Indonesia.</p>\n<p>Over the past couple of weeks, Novavax completed regulatory submissions in the United Kingdom, Australia, Canada, European Union, India, New Zealand, and the Philippines. The company and its partner, Serum Institute of India, also filed for Emergency Use Listing (EUL) for NVX-CoV2373 with the World Health Organization.</p>\n<p>There's <a href=\"https://laohu8.com/S/AONE.U\">one</a> other major market that Novavax is targeting -- the U.S. But the company confirmed in its Q3 update that it still expects to complete its submission to the U.S. Food and Drug Administration (FDA) by the end of this year.</p>\n<p>Novavax has been plagued with manufacturing issues that caused its filing delays earlier this year. However, the company said that it's able to produce up to 100 million doses per month as of the end of the third quarter. Novavax also believes that it's on track to reach a capacity of 150 million doses per month by year-end and expects to be able to produce over 2 billion doses annually in 2022.</p>\n<h2>2. Its valuation remains attractive</h2>\n<p>I've stated in the past that Novavax stock is absurdly cheap. That's still the case, even with shares rebounding somewhat in recent days. As of the market close on Thursday, Novavax's shares traded at 3.2 times expected earnings and 2.4 times expected sales.</p>\n<p>Obviously, those valuation metrics assume that Novavax will generate sales and profits next year from its COVID-19 vaccine. I think that assumption is more valid than it's ever been.</p>\n<p>Sure, it's possible that Novavax could run into snags securing the authorizations and approvals. But the company clearly thinks that it's resolved the manufacturing problems. The safety and efficacy of NVX-CoV2373 look great. While it isn't a slam dunk, it appears as if Novavax is finally in a strong position to win those much-needed regulatory nods.</p>\n<h2>3. Leading in the COVID/flu combo race</h2>\n<p>Novavax's Q3 update also provided more reason to view the company as the leader in the race to develop a combination COVID-19/flu vaccine. The biotech has completed the enrollment of 642 healthy adults ages 50 to 70 in a phase 1/2 clinical trial of a COVID-NanoFlu combo vaccine at 10 sites in Australia.</p>\n<p>NanoFlu already passed late-stage testing with flying colors last year. However, the company sort of put the promising vaccine on the back burner after it shifted its focus on developing a COVID-19 vaccine.</p>\n<p>Novavax expects to report data from the phase 1/2 study in the first half of next year. That puts it well ahead of rivals. <b>Moderna</b>, for example, is evaluating an experimental flu vaccine in phase 1 testing. The company has also announced a new combo COVID/flu candidate but hasn't advanced it into clinical testing yet.</p>\n<p>There's a good chance that COVID-19 will be similar to the flu after the pandemic ends, requiring annual vaccinations. If that's the case, a combination COVID/flu vaccine would likely be quite attractive because of its convenience and potential to increase vaccination rates.</p>\n<p>Novavax just might be the early winner in this market if all goes well with its clinical testing.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>It's Time to Buy Novavax After the Biotech's Q3 Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIt's Time to Buy Novavax After the Biotech's Q3 Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 18:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/05/its-time-to-buy-novavax-after-the-biotechs-q3-upda/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax (NASDAQ:NVAX) has given plenty of reasons for skeptics to doubt whether or not it would be successful. You can go back to the company's multiple flops in clinical trials of its experimental ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/05/its-time-to-buy-novavax-after-the-biotechs-q3-upda/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/11/05/its-time-to-buy-novavax-after-the-biotechs-q3-upda/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2181717655","content_text":"Novavax (NASDAQ:NVAX) has given plenty of reasons for skeptics to doubt whether or not it would be successful. You can go back to the company's multiple flops in clinical trials of its experimental respiratory syncytial virus vaccine over the past few years. You can also point to Novavax's repeated delays in filing for regulatory approvals and authorizations of its COVID-19 vaccine candidate NVX-Cov2373.\nHowever, Novavax announced its third-quarter results after the market closed on Thursday. I think that it's time to buy this vaccine stock after the biotech's Q3 update. Here are three reasons why.\n1. Regulatory filings are on track\nNovavax's management team at long last were able to point to successes with regulatory filings. NVX-CoV2373 even recently won its first Emergency Use Authorization (EUA) in Indonesia.\nOver the past couple of weeks, Novavax completed regulatory submissions in the United Kingdom, Australia, Canada, European Union, India, New Zealand, and the Philippines. The company and its partner, Serum Institute of India, also filed for Emergency Use Listing (EUL) for NVX-CoV2373 with the World Health Organization.\nThere's one other major market that Novavax is targeting -- the U.S. But the company confirmed in its Q3 update that it still expects to complete its submission to the U.S. Food and Drug Administration (FDA) by the end of this year.\nNovavax has been plagued with manufacturing issues that caused its filing delays earlier this year. However, the company said that it's able to produce up to 100 million doses per month as of the end of the third quarter. Novavax also believes that it's on track to reach a capacity of 150 million doses per month by year-end and expects to be able to produce over 2 billion doses annually in 2022.\n2. Its valuation remains attractive\nI've stated in the past that Novavax stock is absurdly cheap. That's still the case, even with shares rebounding somewhat in recent days. As of the market close on Thursday, Novavax's shares traded at 3.2 times expected earnings and 2.4 times expected sales.\nObviously, those valuation metrics assume that Novavax will generate sales and profits next year from its COVID-19 vaccine. I think that assumption is more valid than it's ever been.\nSure, it's possible that Novavax could run into snags securing the authorizations and approvals. But the company clearly thinks that it's resolved the manufacturing problems. The safety and efficacy of NVX-CoV2373 look great. While it isn't a slam dunk, it appears as if Novavax is finally in a strong position to win those much-needed regulatory nods.\n3. Leading in the COVID/flu combo race\nNovavax's Q3 update also provided more reason to view the company as the leader in the race to develop a combination COVID-19/flu vaccine. The biotech has completed the enrollment of 642 healthy adults ages 50 to 70 in a phase 1/2 clinical trial of a COVID-NanoFlu combo vaccine at 10 sites in Australia.\nNanoFlu already passed late-stage testing with flying colors last year. However, the company sort of put the promising vaccine on the back burner after it shifted its focus on developing a COVID-19 vaccine.\nNovavax expects to report data from the phase 1/2 study in the first half of next year. That puts it well ahead of rivals. Moderna, for example, is evaluating an experimental flu vaccine in phase 1 testing. The company has also announced a new combo COVID/flu candidate but hasn't advanced it into clinical testing yet.\nThere's a good chance that COVID-19 will be similar to the flu after the pandemic ends, requiring annual vaccinations. If that's the case, a combination COVID/flu vaccine would likely be quite attractive because of its convenience and potential to increase vaccination rates.\nNovavax just might be the early winner in this market if all goes well with its clinical testing.","news_type":1},"isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842698235,"gmtCreate":1636167403147,"gmtModify":1636167403273,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Waiting to buy","listText":"Waiting to buy","text":"Waiting to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842698235","repostId":"1127340608","repostType":4,"repost":{"id":"1127340608","pubTimestamp":1636124077,"share":"https://www.laohu8.com/m/news/1127340608?lang=&edition=full","pubTime":"2021-11-05 22:54","market":"us","language":"en","title":"Why Palantir Stock Offers a Bit of Something for Everyone","url":"https://stock-news.laohu8.com/highlight/detail?id=1127340608","media":"InvestorPlace","summary":"PLTR has short-term and long-term opportunities","content":"<p>I first came in contact with&nbsp;<b>Palantir</b>(NYSE:<b><u>PLTR</u></b>) stock earlier this year and immediately knew it was something special. The underlying bullish thesis was clear, so I traded it successfully in the past few months. The easiest opportunities came when it fell in sympathy to other small-cap stocks.</p>\n<p>The problem with it is that it is temporarily part of the&nbsp;<b>Reddit</b>&nbsp;cohort of stocks. That’s a “problem” because Palantir has fundamentals that are near bulletproof.</p>\n<p>The company doesn’t need to be moving with others stocks — meme stocks — that have far more questionable scenarios. PLTR stock does not deserve to rally this fast in both directions.</p>\n<p>I was lucky enough to be long it when it spiked with the&nbsp;<b>GameStop</b>(NYSE:<b><u>GME</u></b>) storm in February. It almost hit $46 per share, then came crashing down too fast. Those who didn’t book profits at the top had a nasty reversal on their hands.</p>\n<p>Since then it has continued to whipsaw violently, but in a tighter range. This opened the door for actively trading it for profit. The plan was simple: Buy the dips and sell the rips.</p>\n<p>Some of the easiest wins have come from selling puts on bad days under $20 per share. These are bullish positions that leave room for error.</p>\n<p><b>PLTR Stock Will Be Up If Markets Are Up</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/342d022bee850ad91028eeea1f7f4f7c\" tg-width=\"1549\" tg-height=\"808\" width=\"100%\" height=\"auto\"><span>Source: Charts by TradingView</span></p>\n<p>In the long run, I am confident that if the stock markets are higher, than so is Palantir. It it important to note that shorter term, I am not a perma-bull.</p>\n<p>I have been realistic about the levels where it has resistance. For example I stopped my friends from chasing it in September near $30 per share. Sure enough, it failed and corrected 20% during the September market-wide spat.</p>\n<p>Since then PLTR stock found footing and rallied back 17%. Are you dizzy yet? It gets better because I expect the bulls to eventually go above $30. And when they do that, they go for another 20% from there.</p>\n<p>Meanwhile, the short-term strategy remains to trade the range until one of the sides fails.</p>\n<p>I anticipate that for the foreseeable future, PLTR stock has support near $22 per share. If that fails, then much stronger buyers would step in below $20 … including me. Looking up, there are at least three levels of resistance (see chart). But once past them, the bulls will likely reach $36 per share.</p>\n<p><b>Buy and Hold Will Work for Patient Investors</b></p>\n<p>The fundamentals suggest that it’s probably easiest to just buy the stock and hold it for the long term. The company already has a revenue rate of $1.4 billion. Management recently secured a contract guaranteeing them a 25% increase.</p>\n<p>In short, there’s absolutely nothing wrong with the fundamentals, and the team seems capable. They are in the right business and at the right time. Artificial intelligence (AI) has become an absolute necessity for all businesses. Up until last year, AI was more of a novelty.</p>\n<p>Since the pandemic, the rate of data collection has expanded tremendously. The people can no longer make use of it efficiently to be effective. We will need the help of machines to act on all the bits of information we collect.</p>\n<p>Palantir delivers a setup that empowers users to make decisions on the fly. Moreover, they have two lines of business, one commercial and the other with the government. We all know how much those folks love to overpay for stuff.</p>\n<p>The future is bright for this company and it will be in the lead pack of the stock market.<b>IBM</b>(NYSE:<b><u>IBM</u></b>) would learn a thing or two on how to implement a strategy. They’ve been trying to do this AI thing for decades.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Palantir Stock Offers a Bit of Something for Everyone</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Palantir Stock Offers a Bit of Something for Everyone\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 22:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/11/palantir-pltr-stock-offers-a-bit-of-something-for-everyone/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I first came in contact with Palantir(NYSE:PLTR) stock earlier this year and immediately knew it was something special. The underlying bullish thesis was clear, so I traded it successfully in the past...</p>\n\n<a href=\"https://investorplace.com/2021/11/palantir-pltr-stock-offers-a-bit-of-something-for-everyone/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://investorplace.com/2021/11/palantir-pltr-stock-offers-a-bit-of-something-for-everyone/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127340608","content_text":"I first came in contact with Palantir(NYSE:PLTR) stock earlier this year and immediately knew it was something special. The underlying bullish thesis was clear, so I traded it successfully in the past few months. The easiest opportunities came when it fell in sympathy to other small-cap stocks.\nThe problem with it is that it is temporarily part of the Reddit cohort of stocks. That’s a “problem” because Palantir has fundamentals that are near bulletproof.\nThe company doesn’t need to be moving with others stocks — meme stocks — that have far more questionable scenarios. PLTR stock does not deserve to rally this fast in both directions.\nI was lucky enough to be long it when it spiked with the GameStop(NYSE:GME) storm in February. It almost hit $46 per share, then came crashing down too fast. Those who didn’t book profits at the top had a nasty reversal on their hands.\nSince then it has continued to whipsaw violently, but in a tighter range. This opened the door for actively trading it for profit. The plan was simple: Buy the dips and sell the rips.\nSome of the easiest wins have come from selling puts on bad days under $20 per share. These are bullish positions that leave room for error.\nPLTR Stock Will Be Up If Markets Are Up\nSource: Charts by TradingView\nIn the long run, I am confident that if the stock markets are higher, than so is Palantir. It it important to note that shorter term, I am not a perma-bull.\nI have been realistic about the levels where it has resistance. For example I stopped my friends from chasing it in September near $30 per share. Sure enough, it failed and corrected 20% during the September market-wide spat.\nSince then PLTR stock found footing and rallied back 17%. Are you dizzy yet? It gets better because I expect the bulls to eventually go above $30. And when they do that, they go for another 20% from there.\nMeanwhile, the short-term strategy remains to trade the range until one of the sides fails.\nI anticipate that for the foreseeable future, PLTR stock has support near $22 per share. If that fails, then much stronger buyers would step in below $20 … including me. Looking up, there are at least three levels of resistance (see chart). But once past them, the bulls will likely reach $36 per share.\nBuy and Hold Will Work for Patient Investors\nThe fundamentals suggest that it’s probably easiest to just buy the stock and hold it for the long term. The company already has a revenue rate of $1.4 billion. Management recently secured a contract guaranteeing them a 25% increase.\nIn short, there’s absolutely nothing wrong with the fundamentals, and the team seems capable. They are in the right business and at the right time. Artificial intelligence (AI) has become an absolute necessity for all businesses. Up until last year, AI was more of a novelty.\nSince the pandemic, the rate of data collection has expanded tremendously. The people can no longer make use of it efficiently to be effective. We will need the help of machines to act on all the bits of information we collect.\nPalantir delivers a setup that empowers users to make decisions on the fly. Moreover, they have two lines of business, one commercial and the other with the government. We all know how much those folks love to overpay for stuff.\nThe future is bright for this company and it will be in the lead pack of the stock market.IBM(NYSE:IBM) would learn a thing or two on how to implement a strategy. They’ve been trying to do this AI thing for decades.","news_type":1},"isVote":1,"tweetType":1,"viewCount":427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842691802,"gmtCreate":1636167300542,"gmtModify":1636167300671,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Still TSM is solid","listText":"Still TSM is solid","text":"Still TSM is solid","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/842691802","repostId":"1156595517","repostType":4,"repost":{"id":"1156595517","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636124945,"share":"https://www.laohu8.com/m/news/1156595517?lang=&edition=full","pubTime":"2021-11-05 23:09","market":"us","language":"en","title":"Semiconductor stocks climbed in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1156595517","media":"Tiger Newspress","summary":"Semiconductor stocks climbed in morning trading.Qualcomm,Nvidia,Intel,NXP Semiconductors NV,Broadcom","content":"<p>Semiconductor stocks climbed in morning trading.Qualcomm,Nvidia,Intel,NXP&nbsp;Semiconductors&nbsp;NV,Broadcom,Micron&nbsp;and&nbsp;AMD&nbsp;rose&nbsp;between 1% and 5%.</p>\n<p><img src=\"https://static.tigerbbs.com/a5432c07e2189854dcd840a054166ac3\" tg-width=\"409\" tg-height=\"418\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor stocks climbed in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor stocks climbed in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-05 23:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Semiconductor stocks climbed in morning trading.Qualcomm,Nvidia,Intel,NXP&nbsp;Semiconductors&nbsp;NV,Broadcom,Micron&nbsp;and&nbsp;AMD&nbsp;rose&nbsp;between 1% and 5%.</p>\n<p><img src=\"https://static.tigerbbs.com/a5432c07e2189854dcd840a054166ac3\" tg-width=\"409\" tg-height=\"418\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司","QCOM":"高通","INTC":"英特尔","NVDA":"英伟达","NXPI":"恩智浦","AVGO":"博通","MICR":"Micron Solutions, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156595517","content_text":"Semiconductor stocks climbed in morning trading.Qualcomm,Nvidia,Intel,NXP Semiconductors NV,Broadcom,Micron and AMD rose between 1% and 5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":444,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842693555,"gmtCreate":1636167222271,"gmtModify":1636167222369,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Watching arkk","listText":"Watching arkk","text":"Watching arkk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842693555","repostId":"2181746364","repostType":4,"repost":{"id":"2181746364","pubTimestamp":1636126384,"share":"https://www.laohu8.com/m/news/2181746364?lang=&edition=full","pubTime":"2021-11-05 23:33","market":"us","language":"en","title":"Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought","url":"https://stock-news.laohu8.com/highlight/detail?id=2181746364","media":"Motley Fool","summary":"ARK Invest went shopping on Thursday, buying into three stocks that have fallen after posting disappointing quarterly results this earnings season.","content":"<p>ARK Invest has become a fund company to watch if you're a growth stock investor, and CEO, chief investment officer, and founder Cathie Wood is a big reason. She helped deliver market-thumping returns to her exchange-traded funds (ETFs) last year. This year has been challenging. She's getting back on track, but there are still a few stocks that aren't joining the general market in celebrating new highs.</p>\n<p><b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b>&nbsp;(NASDAQ:FB), <b>Roku</b>&nbsp;(NASDAQ:ROKU), and <b>Robinhood Markets</b> (NASDAQ:HOOD) are trading 13%, 41%, and 56% below their earlier highs, respectively. ARK Invest added to all three positions on Thursday. Let's see why Wood believes it's a good time to buy these three stocks that all took big hits the day after reporting financial results this earnings season.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F651201%2Fgettyimages-104212737.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"465\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Meta Platforms</h2>\n<p>Until last week, it seemed as if ARK Invest was (like many youngsters out there) losing interest in Facebook. Wood was unloading her stake since late February, selling shares 14 times across her two ETFs that own the leading social networking hub.</p>\n<p>The selling turned to buying last week shortly after Facebook's earnings report. The stock took a hit the day after Facebook -- rebranded as Meta Platforms -- announced fresh financials and a new corporate moniker. A name change won't chase away the thorny whistleblower allegations against the company. Meta's makeover also won't come cheap.</p>\n<p>But the stock has been inching higher since the initial post-earnings swoon. Wood is a buyer, not a seller, of the company now. She added to her position twice last week, and made a third Meta Platforms purchase on Thursday of this week.</p>\n<h2>Roku</h2>\n<p>Shares of Roku tumbled 8% on Thursday after a rough quarterly report. Wood was there, buying the dip. The video streaming platform is going through some growing pains right now. Viewing hours have slowed now that folks are spending more time away from home. It could possibly lose YouTube from its hub for new accounts next month. User growth has also decelerated. There are some near-term challenges on the hardware end as supply chain constraints and rising input costs weigh on its dongle sales and margins.</p>\n<p>The good news is that Roku's monetization has never been better. Ad revenue per user continues to move higher. Roku stock is also now trading lower in 2021 despite growing its audience and fortifying its proprietary offerings. ARK Invest bought shares on Thursday with the stock at a five-month low. Even the best growth investors know that sometimes you have to think like a contrarian.</p>\n<h2>Robinhood Markets</h2>\n<p>The ugliest of the three financial updates came from Robinhood Markets. The online options, crypto, and stock trading platform clocked in last week with 35% year-over-year growth in revenue. Analysts were holding out for a 60% top-line surge. Guidance was even worse.</p>\n<p>Robinhood ended the quarter with fewer funded trading accounts than it had on its platform three months ago. Sequential declines are never a good look. With losses widening and trading volume slipping, Robinhood has gone from disruptor to disrupted. Wood is still a believer. She has added to her position in each of the first four trading days of this week and has been a buyer in eight of the last nine trading days.</p>\n<p>Robinhood has a lot to prove, but with the stock now trading below its IPO price of $38, it's like getting in on a ground-floor opportunity from the basement.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 23:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/05/cathie-wood-goes-bargain-hunting-3-stocks-she-just/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ARK Invest has become a fund company to watch if you're a growth stock investor, and CEO, chief investment officer, and founder Cathie Wood is a big reason. She helped deliver market-thumping returns ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/05/cathie-wood-goes-bargain-hunting-3-stocks-she-just/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF","HOOD":"Robinhood","ROKU":"Roku Inc"},"source_url":"https://www.fool.com/investing/2021/11/05/cathie-wood-goes-bargain-hunting-3-stocks-she-just/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2181746364","content_text":"ARK Invest has become a fund company to watch if you're a growth stock investor, and CEO, chief investment officer, and founder Cathie Wood is a big reason. She helped deliver market-thumping returns to her exchange-traded funds (ETFs) last year. This year has been challenging. She's getting back on track, but there are still a few stocks that aren't joining the general market in celebrating new highs.\nMeta Platforms (NASDAQ:FB), Roku (NASDAQ:ROKU), and Robinhood Markets (NASDAQ:HOOD) are trading 13%, 41%, and 56% below their earlier highs, respectively. ARK Invest added to all three positions on Thursday. Let's see why Wood believes it's a good time to buy these three stocks that all took big hits the day after reporting financial results this earnings season.\nImage source: Getty Images.\nMeta Platforms\nUntil last week, it seemed as if ARK Invest was (like many youngsters out there) losing interest in Facebook. Wood was unloading her stake since late February, selling shares 14 times across her two ETFs that own the leading social networking hub.\nThe selling turned to buying last week shortly after Facebook's earnings report. The stock took a hit the day after Facebook -- rebranded as Meta Platforms -- announced fresh financials and a new corporate moniker. A name change won't chase away the thorny whistleblower allegations against the company. Meta's makeover also won't come cheap.\nBut the stock has been inching higher since the initial post-earnings swoon. Wood is a buyer, not a seller, of the company now. She added to her position twice last week, and made a third Meta Platforms purchase on Thursday of this week.\nRoku\nShares of Roku tumbled 8% on Thursday after a rough quarterly report. Wood was there, buying the dip. The video streaming platform is going through some growing pains right now. Viewing hours have slowed now that folks are spending more time away from home. It could possibly lose YouTube from its hub for new accounts next month. User growth has also decelerated. There are some near-term challenges on the hardware end as supply chain constraints and rising input costs weigh on its dongle sales and margins.\nThe good news is that Roku's monetization has never been better. Ad revenue per user continues to move higher. Roku stock is also now trading lower in 2021 despite growing its audience and fortifying its proprietary offerings. ARK Invest bought shares on Thursday with the stock at a five-month low. Even the best growth investors know that sometimes you have to think like a contrarian.\nRobinhood Markets\nThe ugliest of the three financial updates came from Robinhood Markets. The online options, crypto, and stock trading platform clocked in last week with 35% year-over-year growth in revenue. Analysts were holding out for a 60% top-line surge. Guidance was even worse.\nRobinhood ended the quarter with fewer funded trading accounts than it had on its platform three months ago. Sequential declines are never a good look. With losses widening and trading volume slipping, Robinhood has gone from disruptor to disrupted. Wood is still a believer. She has added to her position in each of the first four trading days of this week and has been a buyer in eight of the last nine trading days.\nRobinhood has a lot to prove, but with the stock now trading below its IPO price of $38, it's like getting in on a ground-floor opportunity from the basement.","news_type":1},"isVote":1,"tweetType":1,"viewCount":367,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":842691802,"gmtCreate":1636167300542,"gmtModify":1636167300671,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Still TSM is solid","listText":"Still TSM is solid","text":"Still TSM is solid","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/842691802","repostId":"1156595517","repostType":4,"repost":{"id":"1156595517","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636124945,"share":"https://www.laohu8.com/m/news/1156595517?lang=&edition=full","pubTime":"2021-11-05 23:09","market":"us","language":"en","title":"Semiconductor stocks climbed in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1156595517","media":"Tiger Newspress","summary":"Semiconductor stocks climbed in morning trading.Qualcomm,Nvidia,Intel,NXP Semiconductors NV,Broadcom","content":"<p>Semiconductor stocks climbed in morning trading.Qualcomm,Nvidia,Intel,NXP&nbsp;Semiconductors&nbsp;NV,Broadcom,Micron&nbsp;and&nbsp;AMD&nbsp;rose&nbsp;between 1% and 5%.</p>\n<p><img src=\"https://static.tigerbbs.com/a5432c07e2189854dcd840a054166ac3\" tg-width=\"409\" tg-height=\"418\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Semiconductor stocks climbed in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSemiconductor stocks climbed in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-05 23:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Semiconductor stocks climbed in morning trading.Qualcomm,Nvidia,Intel,NXP&nbsp;Semiconductors&nbsp;NV,Broadcom,Micron&nbsp;and&nbsp;AMD&nbsp;rose&nbsp;between 1% and 5%.</p>\n<p><img src=\"https://static.tigerbbs.com/a5432c07e2189854dcd840a054166ac3\" tg-width=\"409\" tg-height=\"418\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司","QCOM":"高通","INTC":"英特尔","NVDA":"英伟达","NXPI":"恩智浦","AVGO":"博通","MICR":"Micron Solutions, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156595517","content_text":"Semiconductor stocks climbed in morning trading.Qualcomm,Nvidia,Intel,NXP Semiconductors NV,Broadcom,Micron and AMD rose between 1% and 5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":444,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876456630,"gmtCreate":1637346285190,"gmtModify":1637346285353,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Holding. DCA","listText":"Holding. DCA","text":"Holding. DCA","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876456630","repostId":"1114542201","repostType":2,"repost":{"id":"1114542201","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637335740,"share":"https://www.laohu8.com/m/news/1114542201?lang=&edition=full","pubTime":"2021-11-19 23:29","market":"us","language":"en","title":"Boeing Dreamliner Defects Bog Down Production","url":"https://stock-news.laohu8.com/highlight/detail?id=1114542201","media":"Tiger Newspress","summary":"Boeing stock dropped 4% in morning trading as Boeing Dreamliner defected bog down production.\n\nBoein","content":"<p>Boeing stock dropped 4% in morning trading&nbsp;as&nbsp;Boeing Dreamliner defected bog down production.</p>\n<p><img src=\"https://static.tigerbbs.com/3c6c1e62a6a6a253da601f54af830508\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Boeing&nbsp;Co.&nbsp;has further slowed production of 787 Dreamliners as&nbsp;it addresses defects&nbsp;that&nbsp;are delaying deliveries of new jets&nbsp;and complicating airlines’ plans, people familiar with the matter said.</p>\n<p>The plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.</p>\n<p>The latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.</p>\n<p>A string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.</p>\n<p>A Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.</p>\n<p>Boeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.</p>\n<p>The company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.</p>\n<p>“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.</p>\n<p>In an Oct. 27 call with analysts, Chief Executive David Calhoun said&nbsp;defective titanium parts&nbsp;were the “long pole in the tent” among remaining production problems to address.</p>\n<p>The door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing&nbsp;has largely been dealing with tiny gaps&nbsp;where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.</p>\n<p>The Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.</p>\n<p>None of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.</p>\n<p>With deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.</p>\n<p>The delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.</p>\n<p>American Airlines Group&nbsp;Inc.&nbsp;said it had trimmed its flying plans due to the delayed arrival of its new 787s.</p>\n<p>“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.</p>\n<p>The FAA launched a broad review of Boeing’s Dreamliner production in late 2020.</p>\n<p>On Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.</p>\n<p>Representatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Boeing Dreamliner Defects Bog Down Production</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBoeing Dreamliner Defects Bog Down Production\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-19 23:29</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Boeing stock dropped 4% in morning trading&nbsp;as&nbsp;Boeing Dreamliner defected bog down production.</p>\n<p><img src=\"https://static.tigerbbs.com/3c6c1e62a6a6a253da601f54af830508\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Boeing&nbsp;Co.&nbsp;has further slowed production of 787 Dreamliners as&nbsp;it addresses defects&nbsp;that&nbsp;are delaying deliveries of new jets&nbsp;and complicating airlines’ plans, people familiar with the matter said.</p>\n<p>The plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.</p>\n<p>The latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.</p>\n<p>A string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.</p>\n<p>A Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.</p>\n<p>Boeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.</p>\n<p>The company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.</p>\n<p>“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.</p>\n<p>In an Oct. 27 call with analysts, Chief Executive David Calhoun said&nbsp;defective titanium parts&nbsp;were the “long pole in the tent” among remaining production problems to address.</p>\n<p>The door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing&nbsp;has largely been dealing with tiny gaps&nbsp;where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.</p>\n<p>The Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.</p>\n<p>None of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.</p>\n<p>With deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.</p>\n<p>The delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.</p>\n<p>American Airlines Group&nbsp;Inc.&nbsp;said it had trimmed its flying plans due to the delayed arrival of its new 787s.</p>\n<p>“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.</p>\n<p>The FAA launched a broad review of Boeing’s Dreamliner production in late 2020.</p>\n<p>On Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.</p>\n<p>Representatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BA":"波音"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1114542201","content_text":"Boeing stock dropped 4% in morning trading as Boeing Dreamliner defected bog down production.\n\nBoeing Co. has further slowed production of 787 Dreamliners as it addresses defects that are delaying deliveries of new jets and complicating airlines’ plans, people familiar with the matter said.\nThe plane maker is holding off completing the new wide-body jets at its North Charleston, S.C., factory as workers and engineers address problems related to areas surrounding passenger and cargo doors on aircraft already under construction, these people said.\nThe latest production slowdown began in recent days and could last a few weeks as Boeing seeks expertise from other aerospace manufacturers in addressing the door issue, some of these people said. In late October, Boeing disclosed it was producing about two Dreamliners a month, down from a planned monthly rate of five,to resolve production issues.\nA string of production snafus has hampered Boeing’s ability to deliver new Dreamliners for much of the last year, fueling the manufacturer’s financial losses and making it difficult for airlines to build schedules for jets often used in international travel. The plane maker has faced increased scrutiny internally, by air-safety regulators and lawmakers after two of its 737 MAX jets crashed in 2018 and 2019, claiming 346 lives.\nA Boeing spokeswoman said work continues at its Dreamliner factory and production “rates will continue to be dynamic” as the manufacturer focuses on resuming normal assembly, performs inspections and repairs finished aircraft awaiting delivery.\nBoeing is increasingly likely to restart handing over new Dreamliners to its customers in February or March at the earliest, longer than previously anticipated, people familiar with the matter said.\nThe company has been seeking Federal Aviation Administration approval for its proposed pre-delivery inspections to ensure new aircraft meet federal rules and match Boeing’s regulator-approved designs. An FAA spokesman said the agency won’t sign off on inspections until its safety experts are satisfied.\n“This is a case of us looking at every single aspect of design and manufacturing with the airplane, making sure that we’re complying, we’re conforming to the design and we will bring that airplane back as soon as that makes sense,” Ihssane Mounir, Boeing’s commercial sales chief, said Nov. 13 at an air show in Dubai.\nIn an Oct. 27 call with analysts, Chief Executive David Calhoun said defective titanium parts were the “long pole in the tent” among remaining production problems to address.\nThe door issue has since emerged as the most vexing among Boeing’s 787 problems, people familiar with the matter said. Other defects being addressed are related to items such as certain aluminum parts and windows, some of these people said. Boeing has largely been dealing with tiny gaps where sections of the aircraft join together. Such gaps could lead to premature fatigue that may require repairs sooner than anticipated.\nThe Boeing spokeswoman said the company is confident its approach would lead to stability in its 787 production. “We are taking the time needed to ensure the highest levels of quality,” she said.\nNone of the defects being addressed pose immediate safety concerns with Dreamliners currently flying, the Boeing spokeswoman said.\nWith deliveries largely halted since October 2020, the Chicago-based aerospace giant said it had built up an inventory of 105 Dreamliners as of the end of the third quarter this year, according to securities filings. The undelivered jets are worth more than $25 billion.\nThe delivery halt has choked off an important source of cash flow for Boeing as it emerges from the coronavirus pandemic’s blow to aircraft demand. It is also complicating airlines’ plans as international travel rebounds. Dreamliners are Boeing’s flagship wide-body jets and are often used on long-haul flights.\nAmerican Airlines Group Inc. said it had trimmed its flying plans due to the delayed arrival of its new 787s.\n“Due to the continued uncertainty in the delivery schedule, we have proactively removed these aircraft from our winter schedule to minimize potential passenger disruption,” Derek Kerr, the airline’s finance chief, said on an Oct. 21 earnings call.\nThe FAA launched a broad review of Boeing’s Dreamliner production in late 2020.\nOn Thursday, Democratic and Republican leaders of the U.S. House Transportation Committee and its aviation subcommittee requested that the Department of Transportation’s inspector general review the FAA’s manufacturing oversight and “the effectiveness of the FAA’s actions to resolve 787 production issues,” according to a letter reviewed by The Wall Street Journal.\nRepresentatives of the DOT’s inspector general’s office didn’t immediately respond to requests for comment.","news_type":1},"isVote":1,"tweetType":1,"viewCount":620,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601258235,"gmtCreate":1638538429344,"gmtModify":1638538429344,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Thanks","listText":"Thanks","text":"Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/601258235","repostId":"1164605320","repostType":2,"repost":{"id":"1164605320","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638538539,"share":"https://www.laohu8.com/m/news/1164605320?lang=&edition=full","pubTime":"2021-12-03 21:35","market":"us","language":"en","title":"Toplines Before US Market Open on Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1164605320","media":"Tiger Newspress","summary":"U.S. stock index futures gains as headline number for jobs report comes in lighter than expected.At 8:34 a.m. ET, Dow e-minis were up 121 points, or 0.35%, S&P 500 e-minis were up 20.5 points, or 0.45%, and Nasdaq 100 e-minis were up 103.25 points, or 0.65%.The U.S. economy created far fewer jobs than expected in November, before a new Covid threat created a scare that growth could slow into the winter, the Labor Department reported Friday.Nonfarm payrolls increased by just 210,000 for the month","content":"<p>U.S. stock index futures gains as headline number for jobs report comes in lighter than expected.</p>\n<p>At 8:34 a.m. ET, Dow e-minis were up 121 points, or 0.35%, S&amp;P 500 e-minis were up 20.5 points, or 0.45%, and Nasdaq 100 e-minis were up 103.25 points, or 0.65%.</p>\n<p><img src=\"https://static.tigerbbs.com/20c2b6513372a62312316352a7b69eeb\" tg-width=\"404\" tg-height=\"183\" referrerpolicy=\"no-referrer\"></p>\n<p>The U.S. economy created far fewer jobs than expected in November, before a new Covid threat created a scare that growth could slow into the winter, the Labor Department reported Friday.</p>\n<p>Nonfarm payrolls increased by just 210,000 for the month, though the unemployment rate fell sharply to 4.2% from 4.6%, even though the labor force participation rate increased for the month to 61.8%, its highest level since March 2020.</p>\n<p>The Dow Jones estimate was for 573,000 new jobs and a jobless level of 4.5%.</p>\n<p><b>Stocks making the biggest moves before the bell:</b></p>\n<p><b>DocuSign(DOCU) </b>- The software stock sank 32% after its&nbsp;fourth-quarter sales guidance came in at a range of $557 million to $563 million. Analysts surveyed by Refinitiv were expecting $573.8 million.</p>\n<p><b>Didi Global(DIDI) </b>- Shares of the Chinese ride-hailing firm&nbsp;dropped 10% in premarket trading&nbsp;after Didi announced that it would delist from the New York Stock Exchange and pursue a listing in Hong Kong.</p>\n<p><b>Peloton(PTON)</b> - The exercise equipment stock gained 3.7% before the bell following an&nbsp;initiation at buy from Deutsche Bank. The investment firm said that Peloton’s upside now outweighed its risks after a rough stretch for the stock.</p>\n<p><b>Moderna(MRNA) </b>- The volatile shares of the vaccine maker jumped 5.8% as the&nbsp;Wall Street Journal&nbsp;reported that the Food and Drug Administration is working toward a quick review process for updated Covid shots.</p>\n<p><b>Ulta Beauty(ULTA)</b> - The cosmetics retailer’s stock rose more than 5% after a stronger-than-expected third-quarter report. Ulta earned $3.93 per share on $2 billion in revenue during the quarter. Analysts surveyed by Refinitiv had expected $2.46 per share and $1.88 billion in revenue.</p>\n<p><b>Marvell Technology(MRVL)</b> - Shares of the chipmaker jumped 22% in premarket trading after Marvell beat estimates on the top and bottom lines for the third quarter. Marvell reported adjusted earnings of 43 cents per share on $1.21 billion of revenue. Analysts surveyed by Refinitiv were looking for 39 cents per share and $1.15 billion.</p>\n<p><b>Ollie's Bargain Outlet(OLLI) </b>- The discount retail chain's stock dropped 22.8% after Ollie's said supply chain issues led to a disappointing third-quarter report. The company missed estimates for earnings, revenue and comparable sales.</p>\n<p><b>Big Lots(BIG)</b> - The retail stock dipped 2.5% despite Big Lots reporting a narrower-than-expected loss per share for the third quarter. The company said that freight costs would make its full-year margins decline.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-03 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock index futures gains as headline number for jobs report comes in lighter than expected.</p>\n<p>At 8:34 a.m. ET, Dow e-minis were up 121 points, or 0.35%, S&amp;P 500 e-minis were up 20.5 points, or 0.45%, and Nasdaq 100 e-minis were up 103.25 points, or 0.65%.</p>\n<p><img src=\"https://static.tigerbbs.com/20c2b6513372a62312316352a7b69eeb\" tg-width=\"404\" tg-height=\"183\" referrerpolicy=\"no-referrer\"></p>\n<p>The U.S. economy created far fewer jobs than expected in November, before a new Covid threat created a scare that growth could slow into the winter, the Labor Department reported Friday.</p>\n<p>Nonfarm payrolls increased by just 210,000 for the month, though the unemployment rate fell sharply to 4.2% from 4.6%, even though the labor force participation rate increased for the month to 61.8%, its highest level since March 2020.</p>\n<p>The Dow Jones estimate was for 573,000 new jobs and a jobless level of 4.5%.</p>\n<p><b>Stocks making the biggest moves before the bell:</b></p>\n<p><b>DocuSign(DOCU) </b>- The software stock sank 32% after its&nbsp;fourth-quarter sales guidance came in at a range of $557 million to $563 million. Analysts surveyed by Refinitiv were expecting $573.8 million.</p>\n<p><b>Didi Global(DIDI) </b>- Shares of the Chinese ride-hailing firm&nbsp;dropped 10% in premarket trading&nbsp;after Didi announced that it would delist from the New York Stock Exchange and pursue a listing in Hong Kong.</p>\n<p><b>Peloton(PTON)</b> - The exercise equipment stock gained 3.7% before the bell following an&nbsp;initiation at buy from Deutsche Bank. The investment firm said that Peloton’s upside now outweighed its risks after a rough stretch for the stock.</p>\n<p><b>Moderna(MRNA) </b>- The volatile shares of the vaccine maker jumped 5.8% as the&nbsp;Wall Street Journal&nbsp;reported that the Food and Drug Administration is working toward a quick review process for updated Covid shots.</p>\n<p><b>Ulta Beauty(ULTA)</b> - The cosmetics retailer’s stock rose more than 5% after a stronger-than-expected third-quarter report. Ulta earned $3.93 per share on $2 billion in revenue during the quarter. Analysts surveyed by Refinitiv had expected $2.46 per share and $1.88 billion in revenue.</p>\n<p><b>Marvell Technology(MRVL)</b> - Shares of the chipmaker jumped 22% in premarket trading after Marvell beat estimates on the top and bottom lines for the third quarter. Marvell reported adjusted earnings of 43 cents per share on $1.21 billion of revenue. Analysts surveyed by Refinitiv were looking for 39 cents per share and $1.15 billion.</p>\n<p><b>Ollie's Bargain Outlet(OLLI) </b>- The discount retail chain's stock dropped 22.8% after Ollie's said supply chain issues led to a disappointing third-quarter report. The company missed estimates for earnings, revenue and comparable sales.</p>\n<p><b>Big Lots(BIG)</b> - The retail stock dipped 2.5% despite Big Lots reporting a narrower-than-expected loss per share for the third quarter. The company said that freight costs would make its full-year margins decline.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTON":"Peloton Interactive, Inc.",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","BIG":"必乐透","MRVL":"迈威尔科技","OLLI":"Ollie's Bargain Outlet Holdings, Inc.","DIDI":"滴滴(已退市)",".SPX":"S&P 500 Index","DOCU":"Docusign","MRNA":"Moderna, Inc.","ULTA":"Ulta美容"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164605320","content_text":"U.S. stock index futures gains as headline number for jobs report comes in lighter than expected.\nAt 8:34 a.m. ET, Dow e-minis were up 121 points, or 0.35%, S&P 500 e-minis were up 20.5 points, or 0.45%, and Nasdaq 100 e-minis were up 103.25 points, or 0.65%.\n\nThe U.S. economy created far fewer jobs than expected in November, before a new Covid threat created a scare that growth could slow into the winter, the Labor Department reported Friday.\nNonfarm payrolls increased by just 210,000 for the month, though the unemployment rate fell sharply to 4.2% from 4.6%, even though the labor force participation rate increased for the month to 61.8%, its highest level since March 2020.\nThe Dow Jones estimate was for 573,000 new jobs and a jobless level of 4.5%.\nStocks making the biggest moves before the bell:\nDocuSign(DOCU) - The software stock sank 32% after its fourth-quarter sales guidance came in at a range of $557 million to $563 million. Analysts surveyed by Refinitiv were expecting $573.8 million.\nDidi Global(DIDI) - Shares of the Chinese ride-hailing firm dropped 10% in premarket trading after Didi announced that it would delist from the New York Stock Exchange and pursue a listing in Hong Kong.\nPeloton(PTON) - The exercise equipment stock gained 3.7% before the bell following an initiation at buy from Deutsche Bank. The investment firm said that Peloton’s upside now outweighed its risks after a rough stretch for the stock.\nModerna(MRNA) - The volatile shares of the vaccine maker jumped 5.8% as the Wall Street Journal reported that the Food and Drug Administration is working toward a quick review process for updated Covid shots.\nUlta Beauty(ULTA) - The cosmetics retailer’s stock rose more than 5% after a stronger-than-expected third-quarter report. Ulta earned $3.93 per share on $2 billion in revenue during the quarter. Analysts surveyed by Refinitiv had expected $2.46 per share and $1.88 billion in revenue.\nMarvell Technology(MRVL) - Shares of the chipmaker jumped 22% in premarket trading after Marvell beat estimates on the top and bottom lines for the third quarter. Marvell reported adjusted earnings of 43 cents per share on $1.21 billion of revenue. Analysts surveyed by Refinitiv were looking for 39 cents per share and $1.15 billion.\nOllie's Bargain Outlet(OLLI) - The discount retail chain's stock dropped 22.8% after Ollie's said supply chain issues led to a disappointing third-quarter report. The company missed estimates for earnings, revenue and comparable sales.\nBig Lots(BIG) - The retail stock dipped 2.5% despite Big Lots reporting a narrower-than-expected loss per share for the third quarter. The company said that freight costs would make its full-year margins decline.","news_type":1},"isVote":1,"tweetType":1,"viewCount":939,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842698235,"gmtCreate":1636167403147,"gmtModify":1636167403273,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Waiting to buy","listText":"Waiting to buy","text":"Waiting to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842698235","repostId":"1127340608","repostType":4,"repost":{"id":"1127340608","pubTimestamp":1636124077,"share":"https://www.laohu8.com/m/news/1127340608?lang=&edition=full","pubTime":"2021-11-05 22:54","market":"us","language":"en","title":"Why Palantir Stock Offers a Bit of Something for Everyone","url":"https://stock-news.laohu8.com/highlight/detail?id=1127340608","media":"InvestorPlace","summary":"PLTR has short-term and long-term opportunities","content":"<p>I first came in contact with&nbsp;<b>Palantir</b>(NYSE:<b><u>PLTR</u></b>) stock earlier this year and immediately knew it was something special. The underlying bullish thesis was clear, so I traded it successfully in the past few months. The easiest opportunities came when it fell in sympathy to other small-cap stocks.</p>\n<p>The problem with it is that it is temporarily part of the&nbsp;<b>Reddit</b>&nbsp;cohort of stocks. That’s a “problem” because Palantir has fundamentals that are near bulletproof.</p>\n<p>The company doesn’t need to be moving with others stocks — meme stocks — that have far more questionable scenarios. PLTR stock does not deserve to rally this fast in both directions.</p>\n<p>I was lucky enough to be long it when it spiked with the&nbsp;<b>GameStop</b>(NYSE:<b><u>GME</u></b>) storm in February. It almost hit $46 per share, then came crashing down too fast. Those who didn’t book profits at the top had a nasty reversal on their hands.</p>\n<p>Since then it has continued to whipsaw violently, but in a tighter range. This opened the door for actively trading it for profit. The plan was simple: Buy the dips and sell the rips.</p>\n<p>Some of the easiest wins have come from selling puts on bad days under $20 per share. These are bullish positions that leave room for error.</p>\n<p><b>PLTR Stock Will Be Up If Markets Are Up</b></p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/342d022bee850ad91028eeea1f7f4f7c\" tg-width=\"1549\" tg-height=\"808\" width=\"100%\" height=\"auto\"><span>Source: Charts by TradingView</span></p>\n<p>In the long run, I am confident that if the stock markets are higher, than so is Palantir. It it important to note that shorter term, I am not a perma-bull.</p>\n<p>I have been realistic about the levels where it has resistance. For example I stopped my friends from chasing it in September near $30 per share. Sure enough, it failed and corrected 20% during the September market-wide spat.</p>\n<p>Since then PLTR stock found footing and rallied back 17%. Are you dizzy yet? It gets better because I expect the bulls to eventually go above $30. And when they do that, they go for another 20% from there.</p>\n<p>Meanwhile, the short-term strategy remains to trade the range until one of the sides fails.</p>\n<p>I anticipate that for the foreseeable future, PLTR stock has support near $22 per share. If that fails, then much stronger buyers would step in below $20 … including me. Looking up, there are at least three levels of resistance (see chart). But once past them, the bulls will likely reach $36 per share.</p>\n<p><b>Buy and Hold Will Work for Patient Investors</b></p>\n<p>The fundamentals suggest that it’s probably easiest to just buy the stock and hold it for the long term. The company already has a revenue rate of $1.4 billion. Management recently secured a contract guaranteeing them a 25% increase.</p>\n<p>In short, there’s absolutely nothing wrong with the fundamentals, and the team seems capable. They are in the right business and at the right time. Artificial intelligence (AI) has become an absolute necessity for all businesses. Up until last year, AI was more of a novelty.</p>\n<p>Since the pandemic, the rate of data collection has expanded tremendously. The people can no longer make use of it efficiently to be effective. We will need the help of machines to act on all the bits of information we collect.</p>\n<p>Palantir delivers a setup that empowers users to make decisions on the fly. Moreover, they have two lines of business, one commercial and the other with the government. We all know how much those folks love to overpay for stuff.</p>\n<p>The future is bright for this company and it will be in the lead pack of the stock market.<b>IBM</b>(NYSE:<b><u>IBM</u></b>) would learn a thing or two on how to implement a strategy. They’ve been trying to do this AI thing for decades.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Palantir Stock Offers a Bit of Something for Everyone</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Palantir Stock Offers a Bit of Something for Everyone\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 22:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/11/palantir-pltr-stock-offers-a-bit-of-something-for-everyone/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>I first came in contact with Palantir(NYSE:PLTR) stock earlier this year and immediately knew it was something special. The underlying bullish thesis was clear, so I traded it successfully in the past...</p>\n\n<a href=\"https://investorplace.com/2021/11/palantir-pltr-stock-offers-a-bit-of-something-for-everyone/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://investorplace.com/2021/11/palantir-pltr-stock-offers-a-bit-of-something-for-everyone/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127340608","content_text":"I first came in contact with Palantir(NYSE:PLTR) stock earlier this year and immediately knew it was something special. The underlying bullish thesis was clear, so I traded it successfully in the past few months. The easiest opportunities came when it fell in sympathy to other small-cap stocks.\nThe problem with it is that it is temporarily part of the Reddit cohort of stocks. That’s a “problem” because Palantir has fundamentals that are near bulletproof.\nThe company doesn’t need to be moving with others stocks — meme stocks — that have far more questionable scenarios. PLTR stock does not deserve to rally this fast in both directions.\nI was lucky enough to be long it when it spiked with the GameStop(NYSE:GME) storm in February. It almost hit $46 per share, then came crashing down too fast. Those who didn’t book profits at the top had a nasty reversal on their hands.\nSince then it has continued to whipsaw violently, but in a tighter range. This opened the door for actively trading it for profit. The plan was simple: Buy the dips and sell the rips.\nSome of the easiest wins have come from selling puts on bad days under $20 per share. These are bullish positions that leave room for error.\nPLTR Stock Will Be Up If Markets Are Up\nSource: Charts by TradingView\nIn the long run, I am confident that if the stock markets are higher, than so is Palantir. It it important to note that shorter term, I am not a perma-bull.\nI have been realistic about the levels where it has resistance. For example I stopped my friends from chasing it in September near $30 per share. Sure enough, it failed and corrected 20% during the September market-wide spat.\nSince then PLTR stock found footing and rallied back 17%. Are you dizzy yet? It gets better because I expect the bulls to eventually go above $30. And when they do that, they go for another 20% from there.\nMeanwhile, the short-term strategy remains to trade the range until one of the sides fails.\nI anticipate that for the foreseeable future, PLTR stock has support near $22 per share. If that fails, then much stronger buyers would step in below $20 … including me. Looking up, there are at least three levels of resistance (see chart). But once past them, the bulls will likely reach $36 per share.\nBuy and Hold Will Work for Patient Investors\nThe fundamentals suggest that it’s probably easiest to just buy the stock and hold it for the long term. The company already has a revenue rate of $1.4 billion. Management recently secured a contract guaranteeing them a 25% increase.\nIn short, there’s absolutely nothing wrong with the fundamentals, and the team seems capable. They are in the right business and at the right time. Artificial intelligence (AI) has become an absolute necessity for all businesses. Up until last year, AI was more of a novelty.\nSince the pandemic, the rate of data collection has expanded tremendously. The people can no longer make use of it efficiently to be effective. We will need the help of machines to act on all the bits of information we collect.\nPalantir delivers a setup that empowers users to make decisions on the fly. Moreover, they have two lines of business, one commercial and the other with the government. We all know how much those folks love to overpay for stuff.\nThe future is bright for this company and it will be in the lead pack of the stock market.IBM(NYSE:IBM) would learn a thing or two on how to implement a strategy. They’ve been trying to do this AI thing for decades.","news_type":1},"isVote":1,"tweetType":1,"viewCount":427,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842693555,"gmtCreate":1636167222271,"gmtModify":1636167222369,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Watching arkk","listText":"Watching arkk","text":"Watching arkk","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/842693555","repostId":"2181746364","repostType":4,"repost":{"id":"2181746364","pubTimestamp":1636126384,"share":"https://www.laohu8.com/m/news/2181746364?lang=&edition=full","pubTime":"2021-11-05 23:33","market":"us","language":"en","title":"Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought","url":"https://stock-news.laohu8.com/highlight/detail?id=2181746364","media":"Motley Fool","summary":"ARK Invest went shopping on Thursday, buying into three stocks that have fallen after posting disappointing quarterly results this earnings season.","content":"<p>ARK Invest has become a fund company to watch if you're a growth stock investor, and CEO, chief investment officer, and founder Cathie Wood is a big reason. She helped deliver market-thumping returns to her exchange-traded funds (ETFs) last year. This year has been challenging. She's getting back on track, but there are still a few stocks that aren't joining the general market in celebrating new highs.</p>\n<p><b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b>&nbsp;(NASDAQ:FB), <b>Roku</b>&nbsp;(NASDAQ:ROKU), and <b>Robinhood Markets</b> (NASDAQ:HOOD) are trading 13%, 41%, and 56% below their earlier highs, respectively. ARK Invest added to all three positions on Thursday. Let's see why Wood believes it's a good time to buy these three stocks that all took big hits the day after reporting financial results this earnings season.</p>\n<p class=\"t-img-caption\"><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F651201%2Fgettyimages-104212737.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"465\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<h2>Meta Platforms</h2>\n<p>Until last week, it seemed as if ARK Invest was (like many youngsters out there) losing interest in Facebook. Wood was unloading her stake since late February, selling shares 14 times across her two ETFs that own the leading social networking hub.</p>\n<p>The selling turned to buying last week shortly after Facebook's earnings report. The stock took a hit the day after Facebook -- rebranded as Meta Platforms -- announced fresh financials and a new corporate moniker. A name change won't chase away the thorny whistleblower allegations against the company. Meta's makeover also won't come cheap.</p>\n<p>But the stock has been inching higher since the initial post-earnings swoon. Wood is a buyer, not a seller, of the company now. She added to her position twice last week, and made a third Meta Platforms purchase on Thursday of this week.</p>\n<h2>Roku</h2>\n<p>Shares of Roku tumbled 8% on Thursday after a rough quarterly report. Wood was there, buying the dip. The video streaming platform is going through some growing pains right now. Viewing hours have slowed now that folks are spending more time away from home. It could possibly lose YouTube from its hub for new accounts next month. User growth has also decelerated. There are some near-term challenges on the hardware end as supply chain constraints and rising input costs weigh on its dongle sales and margins.</p>\n<p>The good news is that Roku's monetization has never been better. Ad revenue per user continues to move higher. Roku stock is also now trading lower in 2021 despite growing its audience and fortifying its proprietary offerings. ARK Invest bought shares on Thursday with the stock at a five-month low. Even the best growth investors know that sometimes you have to think like a contrarian.</p>\n<h2>Robinhood Markets</h2>\n<p>The ugliest of the three financial updates came from Robinhood Markets. The online options, crypto, and stock trading platform clocked in last week with 35% year-over-year growth in revenue. Analysts were holding out for a 60% top-line surge. Guidance was even worse.</p>\n<p>Robinhood ended the quarter with fewer funded trading accounts than it had on its platform three months ago. Sequential declines are never a good look. With losses widening and trading volume slipping, Robinhood has gone from disruptor to disrupted. Wood is still a believer. She has added to her position in each of the first four trading days of this week and has been a buyer in eight of the last nine trading days.</p>\n<p>Robinhood has a lot to prove, but with the stock now trading below its IPO price of $38, it's like getting in on a ground-floor opportunity from the basement.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 23:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/05/cathie-wood-goes-bargain-hunting-3-stocks-she-just/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ARK Invest has become a fund company to watch if you're a growth stock investor, and CEO, chief investment officer, and founder Cathie Wood is a big reason. She helped deliver market-thumping returns ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/05/cathie-wood-goes-bargain-hunting-3-stocks-she-just/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKK":"ARK Innovation ETF","HOOD":"Robinhood","ROKU":"Roku Inc"},"source_url":"https://www.fool.com/investing/2021/11/05/cathie-wood-goes-bargain-hunting-3-stocks-she-just/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2181746364","content_text":"ARK Invest has become a fund company to watch if you're a growth stock investor, and CEO, chief investment officer, and founder Cathie Wood is a big reason. She helped deliver market-thumping returns to her exchange-traded funds (ETFs) last year. This year has been challenging. She's getting back on track, but there are still a few stocks that aren't joining the general market in celebrating new highs.\nMeta Platforms (NASDAQ:FB), Roku (NASDAQ:ROKU), and Robinhood Markets (NASDAQ:HOOD) are trading 13%, 41%, and 56% below their earlier highs, respectively. ARK Invest added to all three positions on Thursday. Let's see why Wood believes it's a good time to buy these three stocks that all took big hits the day after reporting financial results this earnings season.\nImage source: Getty Images.\nMeta Platforms\nUntil last week, it seemed as if ARK Invest was (like many youngsters out there) losing interest in Facebook. Wood was unloading her stake since late February, selling shares 14 times across her two ETFs that own the leading social networking hub.\nThe selling turned to buying last week shortly after Facebook's earnings report. The stock took a hit the day after Facebook -- rebranded as Meta Platforms -- announced fresh financials and a new corporate moniker. A name change won't chase away the thorny whistleblower allegations against the company. Meta's makeover also won't come cheap.\nBut the stock has been inching higher since the initial post-earnings swoon. Wood is a buyer, not a seller, of the company now. She added to her position twice last week, and made a third Meta Platforms purchase on Thursday of this week.\nRoku\nShares of Roku tumbled 8% on Thursday after a rough quarterly report. Wood was there, buying the dip. The video streaming platform is going through some growing pains right now. Viewing hours have slowed now that folks are spending more time away from home. It could possibly lose YouTube from its hub for new accounts next month. User growth has also decelerated. There are some near-term challenges on the hardware end as supply chain constraints and rising input costs weigh on its dongle sales and margins.\nThe good news is that Roku's monetization has never been better. Ad revenue per user continues to move higher. Roku stock is also now trading lower in 2021 despite growing its audience and fortifying its proprietary offerings. ARK Invest bought shares on Thursday with the stock at a five-month low. Even the best growth investors know that sometimes you have to think like a contrarian.\nRobinhood Markets\nThe ugliest of the three financial updates came from Robinhood Markets. The online options, crypto, and stock trading platform clocked in last week with 35% year-over-year growth in revenue. Analysts were holding out for a 60% top-line surge. Guidance was even worse.\nRobinhood ended the quarter with fewer funded trading accounts than it had on its platform three months ago. Sequential declines are never a good look. With losses widening and trading volume slipping, Robinhood has gone from disruptor to disrupted. Wood is still a believer. She has added to her position in each of the first four trading days of this week and has been a buyer in eight of the last nine trading days.\nRobinhood has a lot to prove, but with the stock now trading below its IPO price of $38, it's like getting in on a ground-floor opportunity from the basement.","news_type":1},"isVote":1,"tweetType":1,"viewCount":367,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870790830,"gmtCreate":1636645276027,"gmtModify":1636645735060,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Keeping.&nbsp;","listText":"Keeping.&nbsp;","text":"Keeping.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870790830","repostId":"1139881214","repostType":2,"repost":{"id":"1139881214","pubTimestamp":1636619165,"share":"https://www.laohu8.com/m/news/1139881214?lang=&edition=full","pubTime":"2021-11-11 16:26","market":"us","language":"en","title":"Analysts Adjust Palantir Price Targets Post Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1139881214","media":"Benzinga","summary":"Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.\nRBC Ca","content":"<p></p>\n<ul>\n <li><p>Few analysts slashed price targets on<b>Palantir Technologies Inc</b>(NYSE:PLTR)despite the Q3 beat.</p></li>\n <li><p><b>RBC Capital</b>analyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, down from $25, implying a 17% downside.</p></li>\n <li><p>The analyst cites the company's \"mixed\" Q3 results with deceleration in the government business while noting that its commercial acceleration that is being fueled by SPAC investments is \"unsustainable.\"</p></li>\n <li><p>Jaluria adds that his confidence in Palantr's 30% growth is reduced, and he sees the stock's valuation as \"full.\"</p></li>\n <li><p><b>William Blair</b>&nbsp;analyst Kamil Mielczarek says Palantir revenues decelerated in the quarter to 36% year-over-year, down from 49% in the first half of 2021.</p></li>\n <li><p>While Palantir delivered \"strong\" headline numbers, the growth in the second half of 2021 is \"heavily reliant on strategic investments.\"</p></li>\n <li><p>The analyst remains concerned about the business's ability to maintain 30% organic growth over the near term and keeps an Underperform rating on Palantir.</p></li>\n <li><p><b>Citi</b>&nbsp;analyst Tyler Radke states Palantir's decelerating growth \"came into center view\" in Q3 with weakness in both commercial and government.</p></li>\n <li><p>While guidance for Q4 was issued slightly ahead of the Street, it still implies slower growth, even on an easier comparison and with significant tailwinds from SPAC-related customer contracting.</p></li>\n <li><p>He reiterates a Sell rating on the shares with an $18 price target.</p></li>\n <li><p><b>Wolfe Research</b>&nbsp;analyst Alex Zukin lowered the price target to $20 from $25, and maintained a Peer Perform following what he calls an \"interesting\" Q3 report.</p></li>\n <li><p>He notes that shares were down after the announcement, which he blames a \"meaningful top-line deceleration,\" pointing out that total revenues, ex. SPAC-contributions of $373 million grew 29% year-over-year, which Zukin said is up only less than $1 million sequentially from Q2.</p></li>\n <li><p>His lower price target is due to the core growth deceleration as he is \"not yet comfortable assigning a similar confidence interval and multiple to SPAC-based commercial revenue.\"</p></li>\n <li><p><b>Morgan Stanley</b>&nbsp;analyst Keith Weiss raised the price target to $24 from $22, implying a 4% upside.</p></li>\n <li><p>He reiterated an Underweight after delivering another beat versus consensus expectations \"across all key headline metrics\" in Q3.</p></li>\n <li><p>Weiss sees \"signs of slowing underneath the hood\" as a slowdown in core revenue and commercial growth, coupled with a sharper slowdown in the government segment, which opens up the debate on the durability of Palantir's growth.</p></li>\n <li><p><b>Price Action:</b>PLTR shares traded lower by 5.6% at $22.9 on the last check Wednesday.</p></li>\n</ul>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Analysts Adjust Palantir Price Targets Post Q3 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnalysts Adjust Palantir Price Targets Post Q3 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-11 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.\nRBC Capitalanalyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://finance.yahoo.com/news/analysts-adjust-palantir-price-targets-183049561.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139881214","content_text":"Few analysts slashed price targets onPalantir Technologies Inc(NYSE:PLTR)despite the Q3 beat.\nRBC Capitalanalyst Rishi Jaluria downgraded toUnderperform from Sector Performwith a price target of $19, down from $25, implying a 17% downside.\nThe analyst cites the company's \"mixed\" Q3 results with deceleration in the government business while noting that its commercial acceleration that is being fueled by SPAC investments is \"unsustainable.\"\nJaluria adds that his confidence in Palantr's 30% growth is reduced, and he sees the stock's valuation as \"full.\"\nWilliam Blair analyst Kamil Mielczarek says Palantir revenues decelerated in the quarter to 36% year-over-year, down from 49% in the first half of 2021.\nWhile Palantir delivered \"strong\" headline numbers, the growth in the second half of 2021 is \"heavily reliant on strategic investments.\"\nThe analyst remains concerned about the business's ability to maintain 30% organic growth over the near term and keeps an Underperform rating on Palantir.\nCiti analyst Tyler Radke states Palantir's decelerating growth \"came into center view\" in Q3 with weakness in both commercial and government.\nWhile guidance for Q4 was issued slightly ahead of the Street, it still implies slower growth, even on an easier comparison and with significant tailwinds from SPAC-related customer contracting.\nHe reiterates a Sell rating on the shares with an $18 price target.\nWolfe Research analyst Alex Zukin lowered the price target to $20 from $25, and maintained a Peer Perform following what he calls an \"interesting\" Q3 report.\nHe notes that shares were down after the announcement, which he blames a \"meaningful top-line deceleration,\" pointing out that total revenues, ex. SPAC-contributions of $373 million grew 29% year-over-year, which Zukin said is up only less than $1 million sequentially from Q2.\nHis lower price target is due to the core growth deceleration as he is \"not yet comfortable assigning a similar confidence interval and multiple to SPAC-based commercial revenue.\"\nMorgan Stanley analyst Keith Weiss raised the price target to $24 from $22, implying a 4% upside.\nHe reiterated an Underweight after delivering another beat versus consensus expectations \"across all key headline metrics\" in Q3.\nWeiss sees \"signs of slowing underneath the hood\" as a slowdown in core revenue and commercial growth, coupled with a sharper slowdown in the government segment, which opens up the debate on the durability of Palantir's growth.\nPrice Action:PLTR shares traded lower by 5.6% at $22.9 on the last check Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":471,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":842697122,"gmtCreate":1636167670895,"gmtModify":1636167732252,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"I am interested in this","listText":"I am interested in this","text":"I am interested in this","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/842697122","repostId":"2181717655","repostType":4,"repost":{"id":"2181717655","pubTimestamp":1636109010,"share":"https://www.laohu8.com/m/news/2181717655?lang=&edition=full","pubTime":"2021-11-05 18:43","market":"us","language":"en","title":"It's Time to Buy Novavax After the Biotech's Q3 Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2181717655","media":"Motley Fool","summary":"Here are three reasons why.","content":"<p><b>Novavax</b> (NASDAQ:NVAX) has given plenty of reasons for skeptics to doubt whether or not it would be successful. You can go back to the company's multiple flops in clinical trials of its experimental respiratory syncytial virus vaccine over the past few years. You can also point to Novavax's repeated delays in filing for regulatory approvals and authorizations of its COVID-19 vaccine candidate NVX-Cov2373.</p>\n<p>However, Novavax announced its third-quarter results after the market closed on Thursday. I think that it's time to buy this vaccine stock after the biotech's Q3 update. Here are three reasons why.</p>\n<h2>1. Regulatory filings are on track</h2>\n<p>Novavax's management team at long last were able to point to successes with regulatory filings. NVX-CoV2373 even recently won its first Emergency Use Authorization (EUA) in Indonesia.</p>\n<p>Over the past couple of weeks, Novavax completed regulatory submissions in the United Kingdom, Australia, Canada, European Union, India, New Zealand, and the Philippines. The company and its partner, Serum Institute of India, also filed for Emergency Use Listing (EUL) for NVX-CoV2373 with the World Health Organization.</p>\n<p>There's <a href=\"https://laohu8.com/S/AONE.U\">one</a> other major market that Novavax is targeting -- the U.S. But the company confirmed in its Q3 update that it still expects to complete its submission to the U.S. Food and Drug Administration (FDA) by the end of this year.</p>\n<p>Novavax has been plagued with manufacturing issues that caused its filing delays earlier this year. However, the company said that it's able to produce up to 100 million doses per month as of the end of the third quarter. Novavax also believes that it's on track to reach a capacity of 150 million doses per month by year-end and expects to be able to produce over 2 billion doses annually in 2022.</p>\n<h2>2. Its valuation remains attractive</h2>\n<p>I've stated in the past that Novavax stock is absurdly cheap. That's still the case, even with shares rebounding somewhat in recent days. As of the market close on Thursday, Novavax's shares traded at 3.2 times expected earnings and 2.4 times expected sales.</p>\n<p>Obviously, those valuation metrics assume that Novavax will generate sales and profits next year from its COVID-19 vaccine. I think that assumption is more valid than it's ever been.</p>\n<p>Sure, it's possible that Novavax could run into snags securing the authorizations and approvals. But the company clearly thinks that it's resolved the manufacturing problems. The safety and efficacy of NVX-CoV2373 look great. While it isn't a slam dunk, it appears as if Novavax is finally in a strong position to win those much-needed regulatory nods.</p>\n<h2>3. Leading in the COVID/flu combo race</h2>\n<p>Novavax's Q3 update also provided more reason to view the company as the leader in the race to develop a combination COVID-19/flu vaccine. The biotech has completed the enrollment of 642 healthy adults ages 50 to 70 in a phase 1/2 clinical trial of a COVID-NanoFlu combo vaccine at 10 sites in Australia.</p>\n<p>NanoFlu already passed late-stage testing with flying colors last year. However, the company sort of put the promising vaccine on the back burner after it shifted its focus on developing a COVID-19 vaccine.</p>\n<p>Novavax expects to report data from the phase 1/2 study in the first half of next year. That puts it well ahead of rivals. <b>Moderna</b>, for example, is evaluating an experimental flu vaccine in phase 1 testing. The company has also announced a new combo COVID/flu candidate but hasn't advanced it into clinical testing yet.</p>\n<p>There's a good chance that COVID-19 will be similar to the flu after the pandemic ends, requiring annual vaccinations. If that's the case, a combination COVID/flu vaccine would likely be quite attractive because of its convenience and potential to increase vaccination rates.</p>\n<p>Novavax just might be the early winner in this market if all goes well with its clinical testing.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>It's Time to Buy Novavax After the Biotech's Q3 Update</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIt's Time to Buy Novavax After the Biotech's Q3 Update\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-05 18:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/05/its-time-to-buy-novavax-after-the-biotechs-q3-upda/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax (NASDAQ:NVAX) has given plenty of reasons for skeptics to doubt whether or not it would be successful. You can go back to the company's multiple flops in clinical trials of its experimental ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/05/its-time-to-buy-novavax-after-the-biotechs-q3-upda/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/11/05/its-time-to-buy-novavax-after-the-biotechs-q3-upda/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2181717655","content_text":"Novavax (NASDAQ:NVAX) has given plenty of reasons for skeptics to doubt whether or not it would be successful. You can go back to the company's multiple flops in clinical trials of its experimental respiratory syncytial virus vaccine over the past few years. You can also point to Novavax's repeated delays in filing for regulatory approvals and authorizations of its COVID-19 vaccine candidate NVX-Cov2373.\nHowever, Novavax announced its third-quarter results after the market closed on Thursday. I think that it's time to buy this vaccine stock after the biotech's Q3 update. Here are three reasons why.\n1. Regulatory filings are on track\nNovavax's management team at long last were able to point to successes with regulatory filings. NVX-CoV2373 even recently won its first Emergency Use Authorization (EUA) in Indonesia.\nOver the past couple of weeks, Novavax completed regulatory submissions in the United Kingdom, Australia, Canada, European Union, India, New Zealand, and the Philippines. The company and its partner, Serum Institute of India, also filed for Emergency Use Listing (EUL) for NVX-CoV2373 with the World Health Organization.\nThere's one other major market that Novavax is targeting -- the U.S. But the company confirmed in its Q3 update that it still expects to complete its submission to the U.S. Food and Drug Administration (FDA) by the end of this year.\nNovavax has been plagued with manufacturing issues that caused its filing delays earlier this year. However, the company said that it's able to produce up to 100 million doses per month as of the end of the third quarter. Novavax also believes that it's on track to reach a capacity of 150 million doses per month by year-end and expects to be able to produce over 2 billion doses annually in 2022.\n2. Its valuation remains attractive\nI've stated in the past that Novavax stock is absurdly cheap. That's still the case, even with shares rebounding somewhat in recent days. As of the market close on Thursday, Novavax's shares traded at 3.2 times expected earnings and 2.4 times expected sales.\nObviously, those valuation metrics assume that Novavax will generate sales and profits next year from its COVID-19 vaccine. I think that assumption is more valid than it's ever been.\nSure, it's possible that Novavax could run into snags securing the authorizations and approvals. But the company clearly thinks that it's resolved the manufacturing problems. The safety and efficacy of NVX-CoV2373 look great. While it isn't a slam dunk, it appears as if Novavax is finally in a strong position to win those much-needed regulatory nods.\n3. Leading in the COVID/flu combo race\nNovavax's Q3 update also provided more reason to view the company as the leader in the race to develop a combination COVID-19/flu vaccine. The biotech has completed the enrollment of 642 healthy adults ages 50 to 70 in a phase 1/2 clinical trial of a COVID-NanoFlu combo vaccine at 10 sites in Australia.\nNanoFlu already passed late-stage testing with flying colors last year. However, the company sort of put the promising vaccine on the back burner after it shifted its focus on developing a COVID-19 vaccine.\nNovavax expects to report data from the phase 1/2 study in the first half of next year. That puts it well ahead of rivals. Moderna, for example, is evaluating an experimental flu vaccine in phase 1 testing. The company has also announced a new combo COVID/flu candidate but hasn't advanced it into clinical testing yet.\nThere's a good chance that COVID-19 will be similar to the flu after the pandemic ends, requiring annual vaccinations. If that's the case, a combination COVID/flu vaccine would likely be quite attractive because of its convenience and potential to increase vaccination rates.\nNovavax just might be the early winner in this market if all goes well with its clinical testing.","news_type":1},"isVote":1,"tweetType":1,"viewCount":483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879271161,"gmtCreate":1636731141461,"gmtModify":1636731141461,"author":{"id":"4097660307195980","authorId":"4097660307195980","name":"ckcy","avatar":"https://static.tigerbbs.com/8040d7ee344d8f248cb6972cf9ecfc80","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Holding","listText":"Holding","text":"Holding","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879271161","repostId":"1154623739","repostType":2,"repost":{"id":"1154623739","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636544529,"share":"https://www.laohu8.com/m/news/1154623739?lang=&edition=full","pubTime":"2021-11-10 19:42","market":"us","language":"en","title":"TSMC shares fell 1.42% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1154623739","media":"Tiger Newspress","summary":"TSMC shares fell 1.42% in premarket trading.\n\nTaiwan Semiconductor Manufacturing Co.'s October reven","content":"<p>TSMC&nbsp;shares&nbsp;fell&nbsp;1.42%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/925cf65fc3c3ace443ec6883f6b03c59\" tg-width=\"878\" tg-height=\"612\" width=\"100%\" height=\"auto\"></p>\n<p>Taiwan Semiconductor Manufacturing Co.'s&nbsp;October revenue&nbsp;was up 12.8% Y/Y to NT$134.54B or about $4.86B.</p>\n<p>The sales were down 11.9% compared to September 2021.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TSMC shares fell 1.42% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTSMC shares fell 1.42% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-10 19:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TSMC&nbsp;shares&nbsp;fell&nbsp;1.42%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/925cf65fc3c3ace443ec6883f6b03c59\" tg-width=\"878\" tg-height=\"612\" width=\"100%\" height=\"auto\"></p>\n<p>Taiwan Semiconductor Manufacturing Co.'s&nbsp;October revenue&nbsp;was up 12.8% Y/Y to NT$134.54B or about $4.86B.</p>\n<p>The sales were down 11.9% compared to September 2021.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSM":"台积电"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154623739","content_text":"TSMC shares fell 1.42% in premarket trading.\n\nTaiwan Semiconductor Manufacturing Co.'s October revenue was up 12.8% Y/Y to NT$134.54B or about $4.86B.\nThe sales were down 11.9% compared to September 2021.","news_type":1},"isVote":1,"tweetType":1,"viewCount":739,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}